{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T20:16:34Z","timestamp":1775852194227,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.ijantimicag.2019.08.023","type":"journal-article","created":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T10:54:13Z","timestamp":1567248853000},"page":"814-819","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Efficacy of antiretroviral compounds against Toxoplasma gondii in vitro"],"prefix":"10.1016","volume":"54","author":[{"given":"Jin-Lei","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hany M.","family":"Elsheikha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting-Ting","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Jun","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-Jie","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin-Li","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing-Quan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0471-1689","authenticated-orcid":false,"given":"Wei","family":"Cong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2019.08.023_bib0001","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1128\/CMR.05013-11","article-title":"Epidemiology of and diagnostic strategies for toxoplasmosis","volume":"25","author":"Robert-Gangneux","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2019.08.023_bib0002","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.cmi.2016.04.025","article-title":"A matched case\u2013control study of toxoplasmosis after allogeneic haematopoietic stem cell transplantation: still a devastating complication","volume":"22","author":"Conrad","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2019.08.023_bib0003","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0140-6736(18)31070-5","article-title":"Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society\u2013Lancet Commission","volume":"392","author":"Bekker","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2019.08.023_bib0004","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/S2352-3018(17)30005-X","article-title":"Prevalence and burden of Toxoplasma gondii infection in HIV-infected people: a systematic review and meta-analysis","volume":"4","author":"Wang","year":"2017","journal-title":"Lancet HIV"},{"key":"10.1016\/j.ijantimicag.2019.08.023_bib0005","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.pt.2004.11.003","article-title":"The impact of HIV-protease inhibitors on opportunistic parasites","volume":"21","author":"Pozio","year":"2005","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.ijantimicag.2019.08.023_bib0006","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1473-3099(12)70348-1","article-title":"HIV-1 protease inhibitors for treatment of visceral leishmaniasis in HIV-co-infected individuals","volume":"13","author":"van Griensven","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.08.023_bib0007","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1128\/AAC.44.9.2575-2577.2000","article-title":"Anti-Toxoplasma activities of antiretroviral drugs and interactions with pyrimethamine and sulfadiazine in vitro","volume":"44","author":"Derouin","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.08.023_bib0008","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/CMR.00102-15","article-title":"Approved antiviral drugs over the past 50 years","volume":"29","author":"De Clercq","year":"2016","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2019.08.023_bib0009","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/infdis\/jiy211","article-title":"Live attenuated Pru:\u0394cdpk2 strain of Toxoplasma gondii protects against acute, chronic, and congenital toxoplasmosis","volume":"218","author":"Wang","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.08.023_bib0010","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/jac\/dkw410","article-title":"Analysis of linezolid and tigecycline as candidates for local prophylaxis via antibiotic-loaded bone cement","volume":"72","author":"Nichol","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2019.08.023_bib0011","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1128\/AAC.03059-15","article-title":"Garcinol inhibits GCN5-mediated lysine acetyltransferase activity and prevents replication of the parasite Toxoplasma gondii","volume":"60","author":"Jeffers","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.08.023_bib0012","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1093\/infdis\/jis602","article-title":"HIV nonnucleoside reverse transcriptase inhibitors and trimethoprim\u2013sulfamethoxazole inhibit Plasmodium liver stages","volume":"206","author":"Hobbs","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.08.023_bib0013","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nature08728","article-title":"An aspartyl protease directs malaria effector proteins to the host cell","volume":"463","author":"Boddey","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ijantimicag.2019.08.023_bib0014","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/j.1600-0854.2007.00589.x","article-title":"A family of aspartic proteases and a novel, dynamic and cell-cycle-dependent protease localization in the secretory pathway of Toxoplasma gondii","volume":"8","author":"Shea","year":"2007","journal-title":"Traffic"},{"key":"10.1016\/j.ijantimicag.2019.08.023_bib0015","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1086\/592280","article-title":"Intracellular survival of Leishmania species that cause visceral leishmaniasis is significantly reduced by HIV-1 protease inhibitors","volume":"198","author":"Trudel","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.08.023_bib0016","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1096\/fj.10-178947","article-title":"HIV proteinase inhibitors target the Ddi1-like protein of Leishmania parasites","volume":"25","author":"White","year":"2011","journal-title":"FASEB J"},{"key":"10.1016\/j.ijantimicag.2019.08.023_bib0017","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1128\/AAC.50.2.639-648.2006","article-title":"Potencies of human immunodeficiency virus protease inhibitors in vitro against Plasmodium falciparum and in vivo against murine malaria","volume":"50","author":"Andrews","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.08.023_bib0018","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/infdis\/jit132","article-title":"HIV treatments have malaria gametocyte killing and transmission blocking activity","volume":"208","author":"Hobbs","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.08.023_bib0019","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.molbiopara.2017.12.003","article-title":"Distinct effects of HIV protease inhibitors and ERAD inhibitors on zygote to ookinete transition of the malaria parasite","volume":"220","author":"Goulielmaki","year":"2018","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.ijantimicag.2019.08.023_bib0020","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.27480","article-title":"A druggable secretory protein maturase of Toxoplasma essential for invasion and egress","volume":"6","author":"Dogga","year":"2017","journal-title":"Elife"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857919302419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857919302419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:33:17Z","timestamp":1760376797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857919302419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S0924857919302419"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.08.023","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of antiretroviral compounds against Toxoplasma gondii in vitro","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.08.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}